167 related articles for article (PubMed ID: 35371663)
1. Pantoprazole-Associated Thrombocytopenia: A Literature Review and Case Report.
Phan AT; Tseng AW; Choudhery MW; Makar JB; Nguyen C; Farmand F
Cureus; 2022 Feb; 14(2):e22326. PubMed ID: 35371663
[TBL] [Abstract][Full Text] [Related]
2. Pantoprazole-induced thrombocytopenia in patients with upper gastrointestinal bleeding.
Binnetoğlu E; Akbal E; Şen H; Güneş F; Erbağ G; Aşık M; Bozkurt N; Uludağ A; Tekin M; Tekin SZ
Platelets; 2015; 26(1):10-2. PubMed ID: 24512269
[TBL] [Abstract][Full Text] [Related]
3. Pre-Endoscopy Use of Proton Pump Inhibitor Intravenous Bolus Dosing in Hemodynamically Stable Patients With Suspected Upper Gastrointestinal Bleeding: Results of a Pharmacist-Managed Hospital Protocol to Reduce Continuous Infusion Pantoprazole Use.
Faust AC; Schwaner L; Thomas D; Sannapanei S; Feldman M
Hosp Pharm; 2022 Aug; 57(4):448-454. PubMed ID: 35898254
[No Abstract] [Full Text] [Related]
4. Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.
Leontiadis GI; Sreedharan A; Dorward S; Barton P; Delaney B; Howden CW; Orhewere M; Gisbert J; Sharma VK; Rostom A; Moayyedi P; Forman D
Health Technol Assess; 2007 Dec; 11(51):iii-iv, 1-164. PubMed ID: 18021578
[TBL] [Abstract][Full Text] [Related]
5. Proton pump induced thrombocytopenia: A case report and review of literature.
Kallam A; Singla A; Silberstein P
Platelets; 2015; 26(6):598-601. PubMed ID: 25207666
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and management of nonvariceal upper gastrointestinal hemorrhage: European Society of Gastrointestinal Endoscopy (ESGE) Guideline.
Gralnek IM; Dumonceau JM; Kuipers EJ; Lanas A; Sanders DS; Kurien M; Rotondano G; Hucl T; Dinis-Ribeiro M; Marmo R; Racz I; Arezzo A; Hoffmann RT; Lesur G; de Franchis R; Aabakken L; Veitch A; Radaelli F; Salgueiro P; Cardoso R; Maia L; Zullo A; Cipolletta L; Hassan C
Endoscopy; 2015 Oct; 47(10):a1-46. PubMed ID: 26417980
[TBL] [Abstract][Full Text] [Related]
7. Pantoprazole-induced Thrombocytopenia: Unresponsive to Corticosteroid and Thrombocyte Concentrate Transfusion.
Widyati ; Latifah N; Ramadhani M
J Pharm Pract; 2023 Jun; 36(3):711-715. PubMed ID: 34965162
[No Abstract] [Full Text] [Related]
8. Intravenous non-high-dose pantoprazole is equally effective as high-dose pantoprazole in preventing rebleeding among low risk patients with a bleeding peptic ulcer after initial endoscopic hemostasis.
Liang CM; Lee JH; Kuo YH; Wu KL; Chiu YC; Chou YP; Hu ML; Tai WC; Chiu KW; Hu TH; Chuah SK
BMC Gastroenterol; 2012 Mar; 12():28. PubMed ID: 22455511
[TBL] [Abstract][Full Text] [Related]
9. Adverse Effects of Proton Pump Inhibitors on Platelet Count: A Case Report and Review of the Literature.
Mukherjee S; Jana T; Pan JJ
Case Rep Gastrointest Med; 2018; 2018():4294805. PubMed ID: 29854491
[TBL] [Abstract][Full Text] [Related]
10. Optimizing proton pump inhibitor therapy for treatment of nonvariceal upper gastrointestinal bleeding.
Worden JC; Hanna KS
Am J Health Syst Pharm; 2017 Feb; 74(3):109-116. PubMed ID: 28122752
[TBL] [Abstract][Full Text] [Related]
11. Lansoprazole-Induced Thrombocytopenia in a Critically Ill Patient: A Case Report.
Saad M; Mitwally H
J Pharm Pract; 2020 Oct; 33(5):700-704. PubMed ID: 30917722
[TBL] [Abstract][Full Text] [Related]
12. Pre-endoscopic proton pump inhibitor therapy reduces recurrent adverse gastrointestinal outcomes in patients with acute non-variceal upper gastrointestinal bleeding.
Keyvani L; Murthy S; Leeson S; Targownik LE
Aliment Pharmacol Ther; 2006 Oct; 24(8):1247-55. PubMed ID: 17014584
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitor-induced neutropenia: possible cross-reactivity between omeprazole and pantoprazole.
Gouraud A; Vochelle V; Descotes J; Vial T
Clin Drug Investig; 2010; 30(8):559-63. PubMed ID: 20586518
[TBL] [Abstract][Full Text] [Related]
14. Pantoprazole for the treatment of peptic ulcer bleeding and prevention of rebleeding.
van Rensburg CJ; Cheer S
Clin Med Insights Gastroenterol; 2012; 5():51-60. PubMed ID: 24833934
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Oral versus Intravenous Proton Pump Inhibitors in Preventing Re-bleeding from Peptic Ulcer after Successful Endoscopic Therapy.
Karim R; Hameed R; Ali K; Tahir A
Cureus; 2020 Jan; 12(1):e6741. PubMed ID: 32133263
[TBL] [Abstract][Full Text] [Related]
16. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?
Clark DW; Strandell J
Eur J Clin Pharmacol; 2006 Jun; 62(6):473-9. PubMed ID: 16758264
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of pantoprozole associated thrombocytopenia in a community hospital.
Dotan E; Katz R; Bratcher J; Wasserman C; Liebman M; Panagopoulos G; Spaccavento C
Expert Opin Pharmacother; 2007 Sep; 8(13):2025-8. PubMed ID: 17714057
[TBL] [Abstract][Full Text] [Related]
18. Pantoprazole: a new proton pump inhibitor.
Jungnickel PW
Clin Ther; 2000 Nov; 22(11):1268-93. PubMed ID: 11117653
[TBL] [Abstract][Full Text] [Related]
19. Patients' Perceptions of Proton Pump Inhibitor Risks and Attempts at Discontinuation: A National Survey.
Kurlander JE; Kennedy JK; Rubenstein JH; Richardson CR; Krein SL; De Vries R; Saini SD
Am J Gastroenterol; 2019 Feb; 114(2):244-249. PubMed ID: 30694867
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor treatment initiated prior to endoscopic diagnosis in upper gastrointestinal bleeding.
Sreedharan A; Martin J; Leontiadis GI; Dorward S; Howden CW; Forman D; Moayyedi P
Cochrane Database Syst Rev; 2010 Jul; 2010(7):CD005415. PubMed ID: 20614440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
